Depression in children and adolescents

American Family Physician

Volumn 62, Issue 10, 2000, Pages 2297-2308

  Son, Sung E ^a   Kirchner, Jeffrey T ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LANCASTER GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMINOPHYLLINE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BARBITURIC ACID; BENZODIAZEPINE; CIMETIDINE; CITALOPRAM; CLOMIPRAMINE; CORTICOSTEROID; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE MALEATE; IMIPRAMINE; IMIPRAMINE PAMOATE; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; ORAL CONTRACEPTIVE AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOFRANIL PM; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VENLAFAXINE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CARDIOTOXICITY; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; ENURESIS; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY;

ADOLESCENT; ADOLESCENT PSYCHOLOGY; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHILD; CHILD PSYCHOLOGY; DEPRESSION; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; PATIENT EDUCATION; REFERRAL AND CONSULTATION; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; TEACHING MATERIALS;

EID: 0034669160     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Birth-cohort trends in rates of major depressive disorder among relatives of patients with affective disorder
2. Depression and suicide in children and adolescents
3. Childhood-onset dysthymic disorder. Clinical features and prospective naturalistic outcome
4. Mood, disorders
5. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders
6. Birth-cohort changes in manic and depressive disorders in relatives of bipolar and schizoaffective patients
7. Childhood and adolescent depression: A review of the past 10 years. Part 1
8. Depressive disorders in childhood. I. A longitudinal prospective study of characteristics and recovery
9. Psychiatric assessment of infant, children, and adolescents
10. The clinical picture of major depression in children and adolescents
11. Phenomenology of depression in children and adolescents
12. Depressive disorders in childhood. II. A longitudinal study of the risk for subsequent major depression
13. Approaches to recognition and management of childhood psychiatric disorders in pediatric primary care
14. The Pediatric Symptom Checklist. Support for a role in a managed care environment
15. Pediatric Symptom Checklist: Screening school-age children for psychosocial dysfunction
16. Historical clues to the diagnosis of the dysfunctional child and other psychiatric disorders in children
17. Cognitive-behavioral therapy of depression and depressive symptoms during adolescence: A review and meta-analysis
18. Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression
19. The use of tricyclic antidepressants in children and adolescents
20. Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis
21. Double-blind, placebo-controlled study of nortriptyline in depressed children using a 'fixed plasma level' design
22. The new anti-depressants. Selective serotonin reuptake inhibitors
23. Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-up
24. A double-blind, randomized, placebo-controrled trial of fluoxetine in children and adolescents with depression
25. An open study of the effects of sertraline on adolescent major depression
26. Newer antidepressants. Beyond selective serotonin reuptake inhibitor anti-depressants
27. Venlafaxine in the treatment of children and adolescents with major depression